Vittia, BRVITTACNOR4

Vittia stock: Q3 net revenue falls 13.3% to BRL 281.7 million

Published on 11/17/2026 at 02:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vittia stock's adjusted net income reached BRL 39.2 million in the quarter. The result fully reversed the adjusted first-half loss.

Profit recovery offsets weaker demand

  • Adjusted net income fully reversed the loss accumulated in the first half of 2026.
  • Management cited tighter farm margins, high financing costs and more selective credit as pressures on demand.
  • The company continued product launches, research spending and shareholder returns during the difficult agricultural cycle.
Vittia, BRVITTACNOR4, Illustration mit AI erstellt.

Vittia reported third-quarter 2026 results on November 11, with net revenue down 13.3% year over year to BRL 281.7 million. The figures were published in Vittia's earnings release.

Adjusted net income reached BRL 39.2 million, with a 13.9% margin, fully reversing the adjusted loss accumulated in the first half. Reported net income was BRL 34.0 million, while adjusted EBITDA reached BRL 68.3 million with a 24.2% margin.

Demand remains under pressure

Management attributed the cautious operating environment to tighter farm margins, elevated financing costs and more selective credit approval. Agricultural indebtedness, uncertainty around the 2026/27 crop season and conservative inventory management also weighed on purchasing decisions.

Revenue from soil fertilizers fell 30.1% year over year to BRL 74.3 million. Foliar fertilizers and industrial products generated BRL 104.3 million, down 5.1%, while biological and natural solutions declined 5.2% to BRL 103.2 million.

Portfolio and capital allocation

Vittia launched four products during 2026: Guardium WP, RizoForte, Aeron-N and Fillus. The company continued investing in research and development and reported BRL 18.5 million of research and development spending for the first nine months.

Net leverage stood at 1.41 times adjusted EBITDA at the end of September. During the first nine months, Vittia allocated BRL 44.7 million to shareholders through share repurchases and interest on equity.

Vittia's business profile

Vittia is a Brazilian biotechnology company focused on biological crop protection, inoculants and specialized plant nutrition. Its reportable divisions are soil fertilizers, foliar fertilizers and industrial products, and biological and natural solutions. The company serves Brazilian agriculture and also sells in international markets.

Vittia company facts

  • Company: Vittia S.A.
  • ISIN: BRVITTACNOR4
  • Ticker: VITT3
  • Primary exchange: B3 Novo Mercado
  • Reporting period: Third quarter of 2026

Brazilian agribusiness shares trade against the backdrop of the Bovespa market environment.

More news and analyses on Vittia stock.

Disclaimer...
en | BRVITTACNOR4 | VITTIA | boerse | 70523759 | bgmi